United States Neuromodulation Devices and Implantable Infusion Pumps Market by Manufacturers, Type and Application, Forecast to 2021

Key driving factors in this market are aging population and chronic diseases. Aging Population: Past few decades have recorded a steeping rise in the population of aging people. Growing number of aging people is directly associated with health issues related with nerves and their activity level. Timely intervention in this activity is becoming essential. Elderly suffering from movement disorders, chronic pain, cardiovascular disorders and other age-related issues are driving the industry. Varied applications of the neurostimulation procedures have vital impact on the global market.

Published by: GIR (GlobalInfoResearch)

Catalog: Healthcare

Publishing Date: Oct 2016

Single User License: USD 4480

Corporate Users License: USD 5680

Delivery time: 24 hours

Pages: 103

Tables and Figures: 131

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=1165[url]

Scope of the Report:

TThis report focuses on the Neuromodulation Devices and Implantable Infusion Pumps in United States market. This report categorizes the market based on manufacturers, type and application.

Market Segment by Manufacturers, this report covers

Medtronic

Boston Scientific Corporation

St. Jude Medical

Synapse Biomedical

Nevro Corporation

Neuropace

Cyberonics

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

Market Segment by Type, covers

Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagal Nerve Stimulation

Gastric Stimulation

Transcranial magnetic Stimulation

Transcutaneous Electrical Stimulation

Other

Market Segment by Applications, can be divided into

Parkinson's disease

Epilepsy

Pain

Other

There are 11 Chapters to deeply display the United States Neuromodulation Devices and Implantable Infusion Pumps market.

Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps Introduction, product scope,...